XBiotech Inc.
XBIT
$3.28
$0.4013.89%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -109.53% | 61.44% | -30.03% | -115.79% | 37.06% |
| Total Depreciation and Amortization | 0.00% | 0.92% | 0.69% | -0.46% | 0.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,482.46% | -136.66% | -52.47% | 451.16% | -127.67% |
| Change in Net Operating Assets | -29.34% | -453.82% | -35.31% | -69.48% | -61.26% |
| Cash from Operations | -11.89% | 48.62% | -57.96% | -109.79% | -130.87% |
| Capital Expenditure | 75.15% | 46.09% | -145.88% | -121.74% | -248.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 75.15% | 46.09% | -145.88% | -121.74% | -100.19% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -48.44% | 33.33% | -12.73% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 342.19% | 33.33% | -99.52% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -679.92% | 227.62% | 64.98% | -214.64% | 189.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.92% | 56.74% | -1,331.20% | 146.86% | -103.69% |
